Allurion becomes debt-free via preferred equity exchange, raises $5M, Q3 revenue falls 50%

ALLURION TECHNOLOGIES, INC.

Exchanged all Notes and RIFA debt for Series B convertible preferred stock with $1,000 stated value, 8.25% dividend; company becomes debt-free.
Raised $5M via private placement at $1.67 per share plus warrant exercisable at $1.67 for five years.
Q3 revenue $2.7M (down 50% YoY); gross margin 49%; operating loss $9.6M (improved 22% YoY); adjusted operating loss $6.9M.
Cash $6.1M at Sep 30 (excluding private placement); operating expenses cut 29% YoY.
FDA cleared pre-approval and BIMO audits with zero observations; entered substantive PMA review; completed Day-100 meeting.

item 1.01 item 2.02 item 3.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

ALLURION TECHNOLOGIES, INC. issued preferred stock to entities managed by RTW Investments, LP.

Security: preferred stock
Purchaser: entities managed by RTW Investments, LP

Exact text from the filing

the Company entered into a securities purchase and exchange agreement (the “Exchange Agreement”) with certain entities managed by RTW Investments, LP (collectively, “RTW”), pursuant to which RTW has agreed to exchange all of the (i) principal amount of convertible senior secured notes

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.95

ALLURION TECHNOLOGIES, INC. issued up to 2,994,012 shares of Common Stock of warrant to certain accredited investors.

Security: warrant
Shares: up to 2,994,012 shares of Common Stock
Purchaser: certain accredited investors

Exact text from the filing

the Company agreed to issue and sell 2,994,012 shares (the “Private Placement Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) and accompanying common warrants to purchase up to 2,994,012 shares of Common Stock (the “Private Placement Warrants,” and together with the Private Placement Shares, the “Private Placement Securities”)

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.95

ALLURION TECHNOLOGIES, INC. issued 2,994,012 shares of common stock to certain accredited investors for aggregate purchase price of approximately $5 million at a purchase price of $1.67 per Private Placement Share and accompanying Private Placement Warrant.

Security: common stock
Shares: 2,994,012 shares
Purchaser: certain accredited investors
Consideration: aggregate purchase price of approximately $5 million at a purchase price of $1.67 per Private Placement Share and accompanying Private Placement Warrant

Exact text from the filing

the Company agreed to issue and sell 2,994,012 shares (the “Private Placement Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) and accompanying common warrants to purchase up to 2,994,012 shares of Common Stock (the “Private Placement Warrants,” and together with the Private Placement Shares, the “Private Placement Securities”), for an aggregate purchase price of approximately $5 million at a purchase price of $1.67 per Private Placement Share and accompanying Private Placement Warrant

View on SEC.gov

Browse all equity issuances →

ALLURION TECHNOLOGIES, INC. filing history →

Source: SEC EDGAR

accession 0001193125-25-276066

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.